Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paclitaxel and Trastuzumab in Metastatic Breast Cancer
NCT00003539Phase 2Completed
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Start
- Apr 1998
- Primary completion
- Feb 2003
- Modality
- Antibody Conjugates, Monoclonal Antibodies, Engineered Antibody Formats
- Countries
- 1
01
Overview
A Phase 2 trial of trastuzumab, paclitaxel in breast cancer, sponsored by Memorial Sloan Kettering Cancer Center. Started Apr 1998; status: completed.
02
Drugs
trastuzumabpaclitaxel
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00003539.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003539.